Evaluation of SARS-CoV-2 antibody titers and potency for convalescent plasma donation: a brief commentary

Vox Sang. 2021 May;116(5):493-496. doi: 10.1111/vox.13060. Epub 2020 Dec 23.

Elise Wouters¹, Maurice Steenhuis², Hubert Schrezenmeier^{3

4}, Pierre Tiberghien^{5

6}, Heli Harvala⁷, Hendrik B Feys¹, Ellen van der Schoot²

¹ Transfusion Research Center, Belgian Red Cross-Flanders, Ghent, Belgium.
² Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, Netherlands.
³ Department of Transfusion Medicine, Ulm University, Ulm, Germany.
⁴ Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-Württemberg - Hessen and University Hospital Ulm, Ulm, Germany.
⁵ Etablissement Français du Sang, La Plaine St-Denis, France.
⁶ UMR1098 RIGHT, INSERM, Etablissement Français du Sang, Université de Franche-Comté, Besançon, France.
⁷ Microbiology Services, NHS Blood and Transplant, London, UK.

No abstract available

Keywords: COVID-19; ELISA; SUPPORT-E; convalescent plasma; neutralization.